| Common Stock, Shares Authorized |
450,000,000 |
shares |
|
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$35,046,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$20,509 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$123,100,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$17,309 |
USD |
|
Q4 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$9,058,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
|
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$5,873,087,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Current State and Local Tax Expense (Benefit) |
$1,396,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$7,662,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$109,282,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$200,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$3,200 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q4 2025 |
FY 2025 |